147 related items for PubMed ID: 10150495
1. Clinical evaluation of CFC-free metered dose inhalers.
Jenkins M.
J Aerosol Med; 1995; 8 Suppl 1():S41-7. PubMed ID: 10150495
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
3. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
4. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
5. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
6. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC, Lindemann L, Braun R, Steinkamp G.
Swiss Med Wkly; 2004 Jan 24; 134(3-4):50-8. PubMed ID: 14745658
[Abstract] [Full Text] [Related]
7. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
Can Respir J; 1999 Jan 24; 6(1):45-51. PubMed ID: 10202220
[Abstract] [Full Text] [Related]
8. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Chopra N, Williams M, Rimmer M, Kahl L, Jenkins M, SMO30006 and SMO30007 International Study Teams.
Respir Med; 2005 Apr 24; 99 Suppl A():S1-S10. PubMed ID: 15777603
[Abstract] [Full Text] [Related]
9. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED, Silins V, Bogolubov M.
Respir Med; 2001 Feb 24; 95(2):136-46. PubMed ID: 11217910
[Abstract] [Full Text] [Related]
10. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM, Andersen LB, Schoaf L, Scott-Wilson CA, Ho SY, Ortega HG.
Ann Allergy Asthma Immunol; 2009 Apr 24; 102(4):323-7. PubMed ID: 19441604
[Abstract] [Full Text] [Related]
11. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P.
J Asthma; 2004 Apr 24; 41(8):797-806. PubMed ID: 15641629
[Abstract] [Full Text] [Related]
12. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
Thorax; 1999 Mar 24; 54(3):207-12. PubMed ID: 10325895
[Abstract] [Full Text] [Related]
13. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar 24; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
14. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.
Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH.
Respir Med; 2003 May 24; 97(5):555-62. PubMed ID: 12735675
[Abstract] [Full Text] [Related]
15. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
Lumry WR, Conway MM, LaForce CF, Pearlman DS, Scott CA, Herje NE, Wu WW, Crim C.
Ann Allergy Asthma Immunol; 2006 Jan 24; 96(1):51-9. PubMed ID: 16440533
[Abstract] [Full Text] [Related]
16. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
Arch Dis Child; 1993 Aug 24; 69(2):206-11. PubMed ID: 8215522
[Abstract] [Full Text] [Related]
17. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
Respir Med; 2000 Jan 24; 94(1):57-63. PubMed ID: 10714480
[Abstract] [Full Text] [Related]
18. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun 24; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
19. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
Respir Med; 2000 Jun 24; 94 Suppl B():S29-34. PubMed ID: 10919683
[Abstract] [Full Text] [Related]
20. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
Currie GP, Stenback S, Lipworth BJ.
Br J Clin Pharmacol; 2003 Jul 24; 56(1):11-7. PubMed ID: 12848770
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
